0001972362-24-000233.txt : 20240228 0001972362-24-000233.hdr.sgml : 20240228 20240228174337 ACCESSION NUMBER: 0001972362-24-000233 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240228 DATE AS OF CHANGE: 20240228 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-33093 FILM NUMBER: 24697483 BUSINESS ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-550-7500 MAIL ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Espinoza Octavio CENTRAL INDEX KEY: 0001905248 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O LIGAND PHARMACEUTICALS INC STREET 2: 3911 SORRENTO VALLEY BOULEVARD, STE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 144 1 primary_doc.xml 144 0001905248 XXXXXXXX LIVE 0000886163 LIGAND PHARMACEUTICALS INC 001-33093 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500 Espinoza Octavio Officer COMMON Morgan Stanley Smith Barney LLC Executive Services

200 W Civic Center Dr - 4th Floor Sandy UT 84070

27725 2459800.00 27000000 02/28/2024 Nasdaq COMMON 02/28/2024 STOCK OPTION EXERCISE ISSUER N 22725 02/28/2024 COMPENSATION COMMON 11/01/2022 RESTRICTED STOCK ISSUER N 2245 11/01/2022 COMPENSATION COMMON 02/15/2023 RESTRICTED STOCK ISSUER N 1609 02/15/2023 COMPENSATION COMMON 10/01/2023 RESTRICTED STOCK ISSUER N 654 10/01/2023 COMPENSATION COMMON 02/15/2024 RESTRICTED STOCK ISSUER N 492 02/15/2024 COMPENSATION Y 02/28/2024 /s/ Octavio Espinoza